Trial intelligence / Profile preview

Fat Grafting with Ex-Vivo Expanded Adipose-Derived Stem Cells for Breast Reconstruction Following Mastectomy

2016-005186-31Phase 3Terminated

Sponsor
Department of Plastic Surgery, Breast and Burns Treatment
Start
Jun 2017
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of autologous adipose-derived mesenchymal stromal cells in breast cancer, BRCA2 gene mutation, breast reconstruction, sponsored by Department of Plastic Surgery, Breast and Burns Treatment. Started Jun 2017; status: terminated.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

breast cancerBRCA2 gene mutationbreast reconstruction

Beyond the preview

Go deeper on 2016-005186-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-005186-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call